ISPE France Affiliate compte environ 300 membres. L'association loi 1901 est pilotée par un Conseil d'Administration de 20 membres qui est responsable de l'animation des évènements organisés chaque année. En outre, le Conseil d'Administration représente l'ISPE France au sein des différents comités et groupes de travail d'ISPE International.
ISPE France Affiliate compte environ 300 membres. L'association loi 1901 est pilotée par un Conseil d'Administration de 20 membres qui est responsable de l'animation des évènements organisés chaque année. En outre, le Conseil d'Administration représente l'ISPE France au sein des différents comités et groupes de travail d'ISPE International.
Pharma Manufacturing Co., Ltd. has been awarded the 2024 ISPE FOYA Category Winner for Social Impact . This recognition highlights their exceptional work on the UK4 project, a
The 2025 Facilities of the Future Conference will explore innovations in facility design and delivery, emerging trends in technologies, manufacturing, and support areas such
In celebration of International Women’s Month, ISPE Philippines Affiliate hosted an evening of networking dubbed Women in Pharma® Soiree – An Evening of Celebration and
This course is focused on how to be compliant in the design, operation & qualification of critical utilities and how to prove it. It comprises four modules including...
This course is designed to help participants understand the GMPs as they relate to the pharmaceutical industry. Participants will gather information about both European...
Specifically targeted to the needs of facility projects within the regulated pharmaceutical industry and demonstrates the value inherent in the use of “good practice” project...
UK4 is a biological drug substance manufacturing facility that was designed and built under a “Three Zeros for Sustainable Development” concept. The three zeros encompass: 1) zero halogenated hydrocarbons, 2) zero...
Attend the 2024 ISPE Annual Meeting & Expo Our comprehensive education program offers cutting-edge technical sessions, shedding light on the latest advancements in areas like supply chain, operations, facilities, and...
This signature gathering is not just an opportunity to learn but also to connect. From emerging talents to seasoned executives in drug manufacturing, supply chain, devices and equipment and services, and global...
The explosive growth of advanced therapy medicinal products (ATMPs), particularly cellular therapeutics, has driven steady investment in facilities capable of manufacturing these therapeutics at scale . Meanwhile, the industry is collectively moving to adapt to...